Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.31)
# 2,681
Out of 5,006 analysts
5
Total ratings
60%
Success rate
10.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.73 | +448.62% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $1.88 | +165.96% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $13.40 | +79.10% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $0.86 | +598.08% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $3.20 | +306.25% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.73
Upside: +448.62%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $1.88
Upside: +165.96%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $13.40
Upside: +79.10%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.86
Upside: +598.08%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $3.20
Upside: +306.25%